Interparfums (NASDAQ:IPAR) Announces Earnings Results

Key Points

• Interparfums earned $2.13 per share, beating the $1.81 analyst consensus by $0.32; revenue of $429.51 million was just below estimates of $430 million.
• Revenue slipped 0.1% year over year, while EPS rose from $2.05 in the same quarter last year.
• Analysts’ consensus rating is Hold, with an average price target of $123.29; shares rose $6.48 to $123.57 in Wednesday midday trading.

Interparfums (NASDAQ:IPAR - Get Free Report) released its quarterly earnings results on Wednesday. The company reported $2.13 earnings per share for the quarter, topping analysts' consensus estimates of $1.81 by $0.32, FiscalAI reports. Interparfums had a return on equity of 15.21% and a net margin of 11.17%. The firm had revenue of $429.51 million during the quarter, compared to the consensus estimate of $430.00 million. During the same quarter in the prior year, the firm posted $2.05 EPS. The business's revenue was down .1% on a year-over-year basis.

Interparfums Stock Performance

Shares of IPAR traded up $6.48 during midday trading on Wednesday, reaching $123.57. The stock had a trading volume of 235,407 shares, compared to its average volume of 204,510. The firm has a 50 day simple moving average of $114.72 and a 200-day simple moving average of $104.97. Interparfums has a one year low of $77.21 and a one year high of $129.29. The firm has a market cap of $3.96 billion, a PE ratio of 22.39 and a beta of 1.08. The company has a current ratio of 3.31, a quick ratio of 2.00 and a debt-to-equity ratio of 0.09.

Analyst Ratings Changes

A number of analysts recently issued reports on IPAR shares. Zacks Research raised Interparfums from a "strong sell" rating to a "hold" rating in a research report on Monday, October 26th. Weiss Ratings reiterated a "hold (c)" rating on shares of Interparfums in a report on Friday, October 2nd. BWS Financial cut Interparfums from a "neutral" rating to a "sell" rating and set a $85.00 price target for the company. in a research report on Monday, August 17th. TD Cowen downgraded Interparfums from a "buy" rating to a "hold" rating and raised their price target for the company from $110.00 to $120.00 in a research note on Monday, August 10th. Finally, The Goldman Sachs Group lowered Interparfums from a "buy" rating to a "neutral" rating and boosted their price target for the stock from $110.00 to $129.00 in a research report on Monday, August 10th. Two investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $123.29.

Insider Buying and Selling at Interparfums

In related news, Director Veronique Gabai-Pinsky sold 900 shares of the firm's stock in a transaction dated Thursday, August 27th. The shares were sold at an average price of $116.86, for a total value of $105,174.00. Following the completion of the sale, the director directly owned 900 shares in the company, valued at approximately $105,174. This trade represents a 50.00% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. 43.60% of the stock is owned by corporate insiders.

About Interparfums

Interparfums, Inc NASDAQ: IPAR develops, manufactures and distributes prestige fragrances and related beauty products. The company operates primarily through licensing agreements with fashion, luxury and lifestyle brands, creating perfumes, colognes, body products and other fragrance-related offerings for men and women.

Its portfolio has included internationally recognized names such as Montblanc, Jimmy Choo, Coach, Kate Spade New York, Rochas, Boucheron, Van Cleef & Arpels, Oscar de la Renta and Karl Lagerfeld, although brand relationships and licensing arrangements may change over time.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.